On-Demand Controlled Drug Delivery
- 454 Downloads
Spatial and temporal control of drug delivery is of prime importance for establishing the therapeutic compliance of drugs for various diseases. Conventional approaches to drug delivery for temporal control of drug delivery include encapsulation, entrapment and conjugation to polymeric materials for obtaining the controlled release. Several macro, micro and nanoformulations have been researched and commercialized for producing controlled release of drugs. Apart from the control over the rate of release, a regional delivery would be highly desirable for increasing the efficacy of the drugs and reducing the undue side effects pertaining to the therapy. Some developments in region specific delivery have been utilizing physiological differences of various sites in the body. Topical formulations have been extensively explored for their region specific delivery due to ease of access of these organs like eye, ear, nasal, oral, vaginal and rectal cavities or parts of gastro-intestinal tract like mouth, stomach, intestine and colon. Several sites of the body have not been reached using drug delivery formulations to selectively deliver the drugs to particular organs due to several physiological barriers. Recent developments and approaches in material chemistry, novel polymers, and technology advancements have led to new avenues in the development of nano/micro-carriers or materials for on-demand controlled drug delivery or stimuli responsive drug delivery. On-demand drug release although complex has become possible due to materials which recognize the microenvironments and react in a dynamic way altering properties to cause release of encapsulated drugs within. The current chapter reviews different approaches of developing on-demand drug release using different materials and techniques.
KeywordsStimuli Responsive On-Demand Drug Delivery Controlled Site-Specific
Rahul Dev Jayant would like to acknowledge financial support from Herbert Wertheim College of Medicine Pilot funding grant (# 800008542); The Campbell Foundation grant (# 800008886); and other support from Center for Personalized Nanomedicine (CPNM) and Institute of Neuro-Immune Pharmacology (INIP) from Department of Immunology, Florida International University (FIU). Abhijeet Joshi acknowledges the INSPIRE Faculty award and fellowship provided by Department of Science and Technology, Government of India. Authors would like acknowledge financial support from DBT and SERB.
- 3.Norum OJ, Gaustad JV, Angell-Petersen E, Rofstad EK, Peng Q, Giercksky KE, Berg K. Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery. Photochem Photobiol. 2009;85(3):740–9. doi: 10.1111/j.1751-1097.2008.00477.x.CrossRefPubMedGoogle Scholar
- 6.Timko BP, Arruebo M, Shankarappa SA, McAlvin JB, Okonkwo OS, Mizrahi B, Stefanescu CF, Gomez L, Zhu J, Zhu A, Santamaria J, Langer R, Kohane DS. Near-infrared–actuated devices for remotely controlled drug delivery. Proc Natl Acad Sci U S A. 2014;111(4):1349–54. doi: 10.1073/pnas.1322651111.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Geethalakshmi A, Karki R, Sagi P, Jha SK, Venkatesh DP. Temperature triggered in-situ gelling system for betaxolol in glaucoma. J Appl Pharm Sci. 2013;3(2):153–9.Google Scholar
- 15.Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, Versteilen AM, Paulus WJ, van Gilst WH, Kooiman K, de Jong N, Musters RJ, Deelman LE, Kamp O. Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res. 2009;104(5):679–87. doi: 10.1161/circresaha.108.183806.CrossRefPubMedGoogle Scholar
- 21.Justin GA, Zhu S, Nicholson TR, Maskrod J, Mbugua J, Chase M, Jung Jh, Mercado RML. On-demand controlled release of anti-inflammatory and analgesic drugs from conducting polymer films to aid in wound healing. In: 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Aug. 28 2012-Sept. 1 2012 2012. pp 1206–1209. doi:10.1109/EMBC.2012.6346153.Google Scholar
- 35.Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Samiei M, Davaran S. Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl. 2012;5:13–25. doi: 10.2147/NSA.S24328.PubMedPubMedCentralGoogle Scholar
- 39.You Han B, Kun N (2005) pH-sensitive polymers for drug delivery. In: Polymeric drug delivery systems. Drugs and the pharmaceutical sciences. Informa Healthcare, pp 129–194. doi: 10.1201/9780849348129.ch3
- 40.Yang M, Cui F, You B, Wang L, Yue P, Kawashima Y. A novel pH-dependent gradient-release delivery system for nitrendipine: II. Investigations of the factors affecting the release behaviors of the system. Int J Pharm. 2004;286(1–2):99–109. doi: 10.1016/j.ijpharm.2004.08.007.CrossRefPubMedGoogle Scholar
- 52.Chi C, Zhang Q, Mao Y, Kou D, Qiu J, Ye J, Wang J, Wang Z, Du Y, Tian J. Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes. Sci Rep. 2015;5:14197. doi: 10.1038/srep14197.CrossRefPubMedPubMedCentralGoogle Scholar
- 54.Bernardos A, Mondragon L, Aznar E, Marcos MD, Martinez-Manez R, Sancenon F, Soto J, Barat JM, Perez-Paya E, Guillem C, Amoros P. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with “saccharides”. ACS Nano. 2010;4(11):6353–68. doi: 10.1021/nn101499d.CrossRefPubMedGoogle Scholar
- 56.Huang P, Gao Y, Lin J, Hu H, Liao H-S, Yan X, Tang Y, Jin A, Song J, Niu G, Zhang G, Horkay F, Chen X. Tumor-specific formation of enzyme-instructed supramolecular self-assemblies as cancer theranostics. ACS Nano. 2015;9(10):9517–27. doi: 10.1021/acsnano.5b03874.CrossRefPubMedPubMedCentralGoogle Scholar